These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11556053)

  • 21. The association between quality improvement activities performed by managed care organizations and quality of care.
    Borenstein J; Badamgarav E; Henning JM; Gano AD; Weingarten SR
    Am J Med; 2004 Sep; 117(5):297-304. PubMed ID: 15336578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global theory and the nature of risk, Part 2. Towards a choice-based model of managed care.
    Emery DW
    Physician Exec; 1999; 25(4):62-6. PubMed ID: 10557488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using knowledge of multiple levels of variation in care to target performance incentives to providers.
    Turenne MN; Hirth RA; Pan Q; Wolfe RA; Messana JM; Wheeler JR
    Med Care; 2008 Feb; 46(2):120-6. PubMed ID: 18219239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P4P: rumors of its demise may be exaggerated.
    Rosenthal MB
    Am J Manag Care; 2007 May; 13(5):238-9. PubMed ID: 17488187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public reporting of quality measures what are we trying to accomplish?
    Califf RM; Peterson ED
    J Am Coll Cardiol; 2009 Mar; 53(10):831-3. PubMed ID: 19264237
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of recent US cost estimates of revascularization.
    Nagle PC; Smith AW
    Am J Manag Care; 2004 Oct; 10(11 Suppl):S370-6. PubMed ID: 15603246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity cost analysis: a tool to cost medical services and improve quality of care.
    Udpa S
    Manag Care Q; 2001; 9(3):34-41. PubMed ID: 11556054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pay for performance: pay more or pay less?
    Swayne LC
    J Am Coll Radiol; 2005 Sep; 2(9):777-81. PubMed ID: 17411926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A focus on the asthma HEDIS measure and its implications for clinical practice.
    Davies TJ; Bunn WB; Fromer L; Gelfand EW; Colice GL
    Manag Care Interface; 2006 Feb; 19(2):29-36. PubMed ID: 16529078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual incentives to fix organizational problems?
    Gray BH
    Med Care Res Rev; 2004 Sep; 61(3 Suppl):76S-9S. PubMed ID: 15375285
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quality assurance in interventional cardiology].
    Gülker H
    Dtsch Med Wochenschr; 2009 Oct; 134 Suppl 6():S192-4. PubMed ID: 19834838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who pays for poor surgical quality? Building a business case for quality improvement.
    Dimick JB; Weeks WB; Karia RJ; Das S; Campbell DA
    J Am Coll Surg; 2006 Jun; 202(6):933-7. PubMed ID: 16735208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment.
    Fendrick AM; Chernew ME
    Am J Manag Care; 2006 Dec; 12 Spec no.():SP5-SP10. PubMed ID: 17173492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managed care and efficient rationing.
    Rosenthal MB; Newhouse JP
    J Health Care Finance; 2002; 28(4):1-10. PubMed ID: 12148660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pay-for-performance in orthopedics: implications for clinical practice.
    Bozic KJ; Smith AR; Mauerhan DR
    J Arthroplasty; 2007 Sep; 22(6 Suppl 2):8-12. PubMed ID: 17823006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial incentives and drug spending in managed care.
    Hillman AL; Pauly MV; Escarce JJ; Ripley K; Gaynor M; Clouse J; Ross R
    LDI Issue Brief; 1999 May; 4(1):1-4. PubMed ID: 12523336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Torts, expertise, and authority: liability of physicians and managed care organizations.
    Arlen J; MacLeod WB
    Rand J Econ; 2005; 36(3):494-519. PubMed ID: 16463455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stats snapshot ... encouraging physicians to adopt information technology to participate in pay-for-performance programs.
    Health Data Manag; 2007 Jun; 15(6):66. PubMed ID: 17853539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.